Cambridge Nutritional Sciences plc (CNSL)
Dec 27, 2024 - CNSL was delisted (reason: acquired by Searchlight and BCI)
4.720
0.00 (0.00%)
Inactive · Last trade price
on Dec 26, 2024
CNSL Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for CNSL.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for CNSL.
Recommendation Trends
| Rating | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Sell Maintains $4 → $2.5 | Strong Sell | Maintains | $4 → $2.5 | -47.03% | Mar 2, 2023 |
| Citigroup | Citigroup | Strong Sell Maintains $5 → $4 | Strong Sell | Maintains | $5 → $4 | -15.25% | Oct 27, 2022 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $7 | Hold | Maintains | $6 → $7 | +48.31% | Aug 4, 2022 |
| Citigroup | Citigroup | Hold → Strong Sell Downgrades $5 | Hold → Strong Sell | Downgrades | $5 | +5.93% | Jul 7, 2022 |
| Citigroup | Citigroup | Strong Sell → Hold Upgrades $4 → $5 | Strong Sell → Hold | Upgrades | $4 → $5 | +5.93% | Mar 8, 2022 |
Financial Forecast
Revenue This Year
1.12B
from 1.11B
Increased by 0.44%
Revenue Next Year
1.12B
from 1.12B
Increased by 0.81%
EPS This Year
-1.44
from -2.60
EPS Next Year
-1.63
from -1.44
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.2B | 1.2B | |
| Avg | 1.1B | 1.1B | |
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 4.6% | 3.8% | |
| Avg | 0.4% | 0.8% | |
| Low | -4.7% | -3.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.48 | -1.68 | |
| Avg | -1.44 | -1.63 | |
| Low | -1.38 | -1.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.